HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukari Takao Selected Research

Peptides (Polypeptides)

9/2007Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.
2/2006Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.
1/2006Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.
2/2005New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients.
1/2004New type of natural antibodies reactive to cytotoxic T lymphocyte-directed cancer vaccine peptides.
1/2004Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukari Takao Research Topics

Disease

4Infections
09/2007 - 01/2004
4Neoplasms (Cancer)
02/2006 - 01/2004
1Hepatitis
11/2008
1Liver Diseases (Liver Disease)
11/2008
1Liver Failure
11/2008
1Persistent Infection
09/2007
1Hepatocellular Carcinoma (Hepatoma)
03/2007
1Alcoholic Hepatitis
11/2006
1Hemolytic Anemia
11/2006
1Carcinoma (Carcinomatosis)
02/2006
1Anaphylaxis (Anaphylactic Shock)
01/2006
1Prostatic Neoplasms (Prostate Cancer)
02/2005
1Osteolysis
02/2005
1Neoplasm Metastasis (Metastasis)
02/2005
1Hypercalcemia (Milk Alkali Syndrome)
02/2005
1Atopic Dermatitis (Atopic Eczema)
01/2004

Drug/Important Bio-Agent (IBA)

6Peptides (Polypeptides)IBA
09/2007 - 01/2004
4Immunoglobulin G (IgG)IBA
09/2007 - 01/2004
3EpitopesIBA
01/2006 - 01/2004
1adefovir dipivoxil (Hepsera)FDA Link
11/2008
1Antiviral Agents (Antivirals)IBA
11/2008
1BilirubinIBA
11/2008
1Prothrombin (Factor II)IBA
11/2008
1Lamivudine (Epivir)FDA Link
11/2008
1InterferonsIBA
03/2007
1PicibanilIBA
02/2006
1Immunoglobulin E (IgE)IBA
01/2006
1AutoantigensIBA
01/2006
1Cancer VaccinesIBA
01/2006
1Proteins (Proteins, Gene)FDA Link
01/2006
1Parathyroid Hormone-Related ProteinIBA
02/2005
1HLA-A2 Antigen (HLA A2 Antigen)IBA
02/2005

Therapy/Procedure

3Therapeutics
03/2007 - 02/2006
2Immunotherapy
01/2006 - 02/2005